New brain scan could spot Alzheimer's earlier
NCT ID NCT05336695
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special PET scan can measure a protein called fibrin in the brains of people with Alzheimer's disease. Researchers will scan 30 volunteers, including healthy older adults and those with Alzheimer's, to see if fibrin levels differ. The goal is to improve diagnosis and understanding of the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 64Cu-FBP8 (a radioactive dye for PET scans)
- What this could lead to
- If successful, this could lead to a new way to detect Alzheimer's disease earlier and more accurately using brain scans.
- What could go wrong
- This is an early-phase study with only 30 participants, so results may not apply widely. The dye is experimental and may not clearly show differences between healthy and affected brains.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?